Ghana malaria vaccine application support
Support Ghana to continue and expand malaria vaccination.
- To support the Ghana Ministry of Health with their application to Gavi, the Vaccine Alliance, for continued funding for and expansion of the malaria vaccine (RTS,S) in a context of scarcity of supply.
Ghana is one of three countries that piloted the malaria vaccine (RTS,S) through the WHO Malaria Vaccine Implementation Programme (MVIP). MMGH supported Ghana in its application to Gavi for support to continue and expand vaccine rollout beyond their MVIP districts. Since vaccine supply was scarce, MMGH made use of lessons learned from the pilot programme, and supported analysis of the malaria disease burden using adjusted malaria incidence, prevalence, and all-cause mortality among children under 5 years in order to prioritize districts for implementation. MMGH also assisted with developing a detailed work plan for the introduction of the campaign in new areas, including components such as communications, logistics, data management and waste management, as well as an associated budget.
Ghana successfully obtained continued funding to expand the rollout of the new malaria vaccine to other areas of the country.